Inventor · disambiguated record
Christopher Fanger
Also filed as: FANGER CHRISTOPHER
29 granted patents·9 pending applications·186 citations·filing 2006–2023
96Inventor score
Files withHYDRA BIOSCIENCES INC14CADENT THERAPEUTICS INC6CHONG JAYHONG A5MORAN MAGDALENE M4NOVARTIS AG4
Top patents by PatentIndex Score
38 records- 0196US11236104B2Heteroaromatic NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2020·Granted Feb 1, 2022·4 cites·28 claims
- 0294US10626122B2Heteroaromatic NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2016·Granted Apr 21, 2020·8 cites·16 claims
- 0394US7671061B2Methods and compositions for treating painHYDRA BIOSCIENCES INC·Filed 2006·Granted Mar 2, 2010·27 cites·8 claims
- 0493US10500205B2Thienopyrimidinone NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2016·Granted Dec 10, 2019·10 cites·22 claims
- 0592US7893260B2Substituted quinazolin-4-one compounds for antagonizing TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2006·Granted Feb 22, 2011·23 cites·13 claims
- 0691US8178542B2Methods and compositions for treating painMORAN MAGDALENE M·Filed 2010·Granted May 15, 2012·13 cites·4 claims
- 0791US7998980B2Compounds for modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2007·Granted Aug 16, 2011·15 cites·10 claims
- 0890US11807650B2NMDA receptor modulators and uses thereofNOVARTIS AG·Filed 2022·Granted Nov 7, 2023·1 cites·17 claims
- 0990US10973825B2Thienopyrimidinone NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2016·Granted Apr 13, 2021·6 cites·16 claims
- 1090US9139573B2Methods and compositions for treating anxietyCHONG JAYHONG A·Filed 2013·Granted Sep 22, 2015·8 cites·1 claims
- 1190US8541423B2Methods and compositions for treating painMORAN MAGDALENE M·Filed 2012·Granted Sep 24, 2013·11 cites·2 claims
- 1289US8389529B2Methods and compositions for treating asthmaMORAN MAGDALENE M·Filed 2010·Granted Mar 5, 2013·11 cites·4 claims
- 1389US7803790B2Compounds for modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2006·Granted Sep 28, 2010·12 cites·10 claims
- 1487US11541057B2Thienopyrimidinone NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2021·Granted Jan 3, 2023·1 cites·9 claims
- 1587US11274107B2NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2017·Granted Mar 15, 2022·3 cites·20 claims
- 1686US8163761B2Methods and compositions for treating disordersNG HOWARD·Filed 2008·Granted Apr 24, 2012·14 cites·5 claims
- 1784US9181219B2Compounds of modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2013·Granted Nov 10, 2015·5 cites·5 claims
- 1882US8916550B2Compounds for modulating TRPV3 functionCHONG JAYHONG A·Filed 2006·Granted Dec 23, 2014·3 cites·26 claims
- 1981US12358929B2NMDA receptor modulators and uses thereofNOVARTIS AG·Filed 2023·Granted Jul 15, 2025·0 cites·14 claims
- 2081US8389546B2Compounds for modulating TRPV3 functionMORAN MAGDALENE M·Filed 2011·Granted Mar 5, 2013·4 cites·14 claims
- 2178US9815838B2Methods and compositions for treating painHYDRA BIOSCIENCES INC·Filed 2013·Granted Nov 14, 2017·2 cites·8 claims
- 2277US10351567B2Methods and compositions for treating painLILLY CO ELI·Filed 2017·Granted Jul 16, 2019·1 cites·4 claims
- 2376US12162890B2Heteroaromatic NMDA receptor modulators and uses thereofNOVARTIS AG·Filed 2021·Granted Dec 10, 2024·0 cites·31 claims
- 2474US11648253B2Thienopyrimidinone NMDA receptor modulators and uses thereofNOVARTIS AG·Filed 2021·Granted May 16, 2023·0 cites·19 claims
- 2574US9486455B2Compounds for modulating TRPV3 functionCHONG JAYHONG A·Filed 2011·Granted Nov 8, 2016·2 cites·13 claims
- 2674US8552009B2Substituted pyrimido 4.5-d pyrimidin-4-one compounds for modulating TRPV3 functionCHONG JAYHONG A·Filed 2011·Granted Oct 8, 2013·2 cites·14 claims
- 2768US8633233B2Methods and compositions for treating anxietyCHONG JAYHONG·Filed 2009·Granted Jan 21, 2014·0 cites·1 claims
- 2864US2015299225A1Compounds for modulating trpv3 functionCHONG JAYHONG A·Filed 2014·Application pending·0 cites
- 2961US2009018147A1Compounds for modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2008·Application pending·0 cites
- 3056US9895356B2Methods and compositions for treating anxietyHYDRA BIOSCIENCES INC·Filed 2015·Granted Feb 20, 2018·0 cites·17 claims
- 3156US2014155417A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 3255US12414927B2CXCR5 antagonists and methods of treating diseases or disorders using sameUNIV YALE·Filed 2021·Granted Sep 16, 2025·0 cites·15 claims
- 3353US2016256447A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2015·Application pending·0 cites
- 3452US2018133170A1Methods and compositions for treating disordersHYDRA BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 3551US2017224687A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 3650US2017020858A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 3748US2013059869A1Methods and compositions for treating disordersNG HOWARD·Filed 2012·Application pending·0 cites
- 3848US2010273777A1Compounds for Modulating TRPV3 FunctionHYDRA BIOSCIENCES INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →